Ectopic expression of BRK increased levels of Akt and Erk phosphorylation, and decreased the efficacy of Cetuximab wherein higher doses of Cetuximab was required to achieve the same level of growth inhibition as compared to control breast cancer cells 16. The gene discussed is AKT1; the disease is breast cancer.